| Next 10 |
Ad
IGMS Articles IGM Biosciences Inc.
home / stock / igms / igms articles
Articles | IGM Biosciences Inc. (NASDAQ:IGMS)
-
Shares of Conagra Brands, Inc. (NYSE:CAG) fell during Thursday's session after the company reported worse-than-expected fourth-quarter sales r...
-
MOUNTAIN VIEW, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ:IGMS), a clinical-stage biotechnology company creating and...
-
Shares of XP Inc. (NASDAQ:XP) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter EPS results...
-
Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering...
-
Investors might want to bet on IGM Biosciences, Inc. (NASDAQ: IGMS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in ...
-
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Als...
-
U.S. stocks were mixed, with the Nasdaq Composite trading almost flat on Monday. Shares of CymaBay Therapeutics, Inc. (NASDAQ: CBAY) rose sharply ...
-
RBC Capital upgraded IGM Biosciences Inc (NASDAQ:IGMS), a biotechnology focused on antibody medicines for cancer. RBC analysts upgraded the stock...
-
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results. Take-Two...
Stock Information
Get IGMS Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-10-01 07:59:56 ET Asthika Goonewardene from Truist Financial issued a price target of $12.00 for IGMS on 2024-10-01 06:52:00. The adjusted price target was set to $12.00. At the time of the announcement, IGMS was trading at $16.54. The overall price target consensus...
-
– Company to prioritize its pipeline of T cell engagers in autoimmune diseases, including ongoing clinical development of imvotamab in rheumatoid arthritis and systemic lupus erythematosus – – Mary Beth Harler, M.D., appointed as Chief Executive Officer and to Board o...
-
MOUNTAIN VIEW, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, and Mary Beth Harler, M.D., Head, Research & ...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the development of the new next generation AABB Wallet App is nearing completion. The AABB Wallet development team, led by the Koinfold Cr...